There are multiple disciplines within BMX freestyle, but the only one contested at the Olympics is BMX park. It takes place on a course that includes features such as ramps, box jumps, walls and ...

Oct. 2, 2024 — Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in ... Cannabinoid CBG Reduces ...

Marijuana’s humid growing conditions are a paradise for dangerous mold. States where marijuana is legal make growers hire laboratories to check for concentrations of mold and other contaminants ...

It's time to end the War on Marijuana. The aggressive enforcement of marijuana possession laws needlessly ensnares hundreds of thousands of people into the criminal justice system and wastes billions ...

Legalizing marijuana at the national level is generally popular with Americans — 57% of people say marijuana should be legal for both medical and recreational purposes, while 32% say it should ...

Marijuana stocks may seem a tempting investment, but make sure you're aware of the associated risks before diving into this burgeoning market. Many, or all, of the products featured on this page ...

Estimates from the most recent iteration of the annual Monitoring the Future survey also show significant increases in the shares of 10th- and 12th-graders who have never used alcohol, marijuana ...

Election Day is Tuesday and in four states, voters will have the opportunity to cast their thoughts on the future of marijuana legislation. On the Florida ballot, Amendment 3 pertains to the ...

Cannabis stocks jumped after the U.S. Department of Health and Human Services recommended easing restrictions on marijuana in August. However, cannabis also has seen slower-than-forecast progress ...

Florida voters heading to the polls on Election Day have the chance to say "yes" or "no" to Amendment 3, which seeks to legalize marijuana for recreational use and change the state's constitution.

Marijuana stocks have given cannabis investors nothing but false starts over the past few years. The industry has struggled with a plethora of issues, including inflation, overproduction, lack of ...

Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News. Vice President ...